AHA News: Adopted Babys Unexpected Heart Problem Brought Unexpected Joy
FRIDAY, Sept. 20, 2019 (American Heart Association News) -- When their hopes of adopting a child from China were stretched thin by years of wait, Vanessa and Chris Zoog asked for a b
FDA Approves Rybelsus
FDA Approves Rybelsus (semaglutide), the First Oral GLP-1 Analog Treatment for Adults with Type 2 Diabetes
PLAINSBORO, N.J., Sept. 20, 2019 /PRNewswire/ -- Novo Nordisk today announced that the U.S. Food and Drug Administration (
Drug Safety Communication: Imodium (loperamide) for Over-the-Counter Use - FDA Limits Packaging To Encourage Safe Use
Audience: Consumer, Pharmacy, Family Practice
[9-20-2019] UPDATE
To help address loperamide abuse and misuse, FDA approved changes t
Women With Heart Attack Do Present With Typical Symptoms
FRIDAY, Sept. 13, 2019 -- Typical symptoms of myocardial infarction are more common and have greater predictive value in women than in men, according to a study published in the Sept. 3 issue of th
FDA Approves Ibsrela (tenapanor) for the Treatment of Irritable Bowel Syndrome with Constipation
FREMONT, Calif., Sept. 12, 2019 /PRNewswire/ -- Ardelyx, Inc. today announced that the U.S. Food and Drug Administration has approved Ibsrela (tenapanor), a
FDA Approves Gvoke
FDA Approves Gvoke (glucagon), the First Ready-to-use Stable Liquid Glucagon for Severe Hypoglycemia
CHICAGO--(BUSINESS WIRE)--Sep. 10, 2019-- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging